These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23052409)

  • 21. Genetic polymorphisms of UGT1A8, UGT1A9, UGT2B7 and ABCC2 in Chinese renal transplant recipients and a comparison with other ethnic populations.
    Deng XY; Wang CX; Wang XD; Bi HC; Chen X; Li JL; Huang M
    Pharmazie; 2013 Apr; 68(4):240-4. PubMed ID: 23700788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration.
    Bullingham R; Monroe S; Nicholls A; Hale M
    J Clin Pharmacol; 1996 Apr; 36(4):315-24. PubMed ID: 8728345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of uridine diphosphate-glucuronosyltransferases (1A9) polymorphisms on mycophenolic acid pharmacokinetics in patients with renal transplant.
    Ciftci HS; Demir E; Karadeniz MS; Tefik T; Nane I; Oguz FS; Aydin F; Turkmen A
    Ren Fail; 2018 Nov; 40(1):395-402. PubMed ID: 30012031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of UGT1A8 and UGT2B7 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.
    Kagaya H; Inoue K; Miura M; Satoh S; Saito M; Tada H; Habuchi T; Suzuki T
    Eur J Clin Pharmacol; 2007 Mar; 63(3):279-88. PubMed ID: 17211619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No pharmacokinetic interactions between mycophenolic acid and tacrolimus in renal transplant recipients.
    Kagaya H; Miura M; Satoh S; Inoue K; Saito M; Inoue T; Habuchi T; Suzuki T
    J Clin Pharm Ther; 2008 Apr; 33(2):193-201. PubMed ID: 18315786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of the UGT1A8, SLCO1B3 and ABCC2/ABCG2 genetic polymorphisms with the pharmacokinetics of mycophenolic acid and its phenolic glucuronide metabolite in Chinese individuals.
    Geng F; Jiao Z; Dao YJ; Qiu XY; Ding JJ; Shi XJ; Li ZD; Zhong MK
    Clin Chim Acta; 2012 Apr; 413(7-8):683-90. PubMed ID: 22227166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of UGT1A7 and UGT1A9 intronic I399 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.
    Inoue K; Miura M; Satoh S; Kagaya H; Saito M; Habuchi T; Suzuki T
    Ther Drug Monit; 2007 Jun; 29(3):299-304. PubMed ID: 17529886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total and free mycophenolic acid and its 7-O-glucuronide metabolite in Chinese adult renal transplant patients: pharmacokinetics and application of limited sampling strategies.
    Jiao Z; Zhong JY; Zhang M; Shi XJ; Yu YQ; Lu WY
    Eur J Clin Pharmacol; 2007 Jan; 63(1):27-37. PubMed ID: 17093994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Exposure of Tacrolimus by Co-administered Mycophenolate Mofetil: Population Pharmacokinetic Analysis in Healthy Volunteers.
    Kim JH; Han N; Kim MG; Yun HY; Lee S; Bae E; Kim YS; Kim IW; Oh JM
    Sci Rep; 2018 Jan; 8(1):1687. PubMed ID: 29374217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in Chinese adult renal transplant recipients.
    Yu ZC; Zhou PJ; Wang XH; Françoise B; Xu D; Zhang WX; Chen B
    Acta Pharmacol Sin; 2017 Nov; 38(11):1566-1579. PubMed ID: 28836585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients.
    Shipkova M; Armstrong VW; Weber L; Niedmann PD; Wieland E; Haley J; Tönshoff B; Oellerich M;
    Ther Drug Monit; 2002 Jun; 24(3):390-9. PubMed ID: 12021631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacogenetic pharmacokinetic modeling for flip-flop phenomenon of enteric-coated mycophenolate sodium in kidney transplant recipients.
    Han N; Yun HY; Kim IW; Oh YJ; Kim YS; Oh JM
    Eur J Clin Pharmacol; 2014 Oct; 70(10):1211-9. PubMed ID: 25163792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacokinetics of mycophenolate mofetil.
    Bullingham RE; Nicholls AJ; Kamm BR
    Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of nonsynonymous polymorphisms of UGT1A8 and UGT2B7 metabolizing enzymes on the formation of phenolic and acyl glucuronides of mycophenolic acid.
    Bernard O; Tojcic J; Journault K; Perusse L; Guillemette C
    Drug Metab Dispos; 2006 Sep; 34(9):1539-45. PubMed ID: 16790554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of uridine diphosphate glucuronosyltransferase 2B7 and 1A7 pharmacogenomics and patient clinical parameters on steady-state mycophenolic acid pharmacokinetics in glomerulonephritis.
    Joy MS; Boyette T; Hu Y; Wang J; La M; Hogan SL; Stewart PW; Falk RJ; Dooley MA; Smith PC
    Eur J Clin Pharmacol; 2010 Nov; 66(11):1119-30. PubMed ID: 20567810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of genetic polymorphisms on pharmacokinetics and treatment response of mycophenolic acid: a scoping review.
    Yow HY; Ikawati M; Siswanto S; Hermawan A; Rahmat AK; Tan JS; Tee YC; Ng KP; Ikawati Z
    Pharmacogenomics; 2024; 25(5-6):259-288. PubMed ID: 38884938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenetic effect of the UGT polymorphisms on mycophenolate is modified by calcineurin inhibitors.
    Johnson LA; Oetting WS; Basu S; Prausa S; Matas A; Jacobson PA
    Eur J Clin Pharmacol; 2008 Nov; 64(11):1047-56. PubMed ID: 18568343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of mycophenolic acid and its glucuronide after a single and multiple oral dose of mycophenolate mofetil in Chinese renal transplantation recipients.
    Liang MZ; Lu YP; Nan F; Li YP
    Transplant Proc; 2006 Sep; 38(7):2044-7. PubMed ID: 16979994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study.
    Rissling O; Glander P; Hambach P; Mai M; Brakemeier S; Klonower D; Halleck F; Singer E; Schrezenmeier EV; Dürr M; Neumayer HH; Budde K
    Br J Clin Pharmacol; 2015 Nov; 80(5):1086-96. PubMed ID: 25913040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T and its influence on mycophenolic acid pharmacokinetics in stable renal transplant patients.
    Sánchez-Fructuoso AI; Maestro ML; Calvo N; Viudarreta M; Pérez-Flores I; Veganzone S; De la Orden V; Ortega D; Arroyo M; Barrientos A
    Transplant Proc; 2009; 41(6):2313-6. PubMed ID: 19715905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.